Latest Health News
World Birth Defects Day: Progress and Persistent Challenges in the Americas
The Pan American Health Organization (PAHO) marks World Birth Defects Day, noting that over 20,000 newborns die annually from birth defects in the Americas, with nearly 22% of first-month deaths associated with congenital conditions. Despite regional progress in reducing neonatal mortality from 12.9 to 7.1 deaths per 1,000 live births between 2000 and 2023, birth defect-related deaths have not declined at the same pace, highlighting persistent inequalities in prevention and specialized care access
.
Revolutionary Type 1 Diabetes Therapy Aims for Complete Cure Without Immunosuppressive Drugs
Scientists are developing a breakthrough stem cell-based therapy combining engineered immune cells with lab-grown insulin-producing beta cells to potentially cure type 1 diabetes. The approach uses modified T-regulatory cells as targeted 'bodyguards' to protect transplanted beta cells from immune rejection, eliminating the need for long-term immunosuppressive medications that carry significant health risks, particularly for children
.
Colorectal Cancer Rising Dramatically in Younger Adults
The American College of Surgeons highlights that colorectal cancer is now the leading cause of cancer death among those age 50 and younger, with notable cases including actor James Van Der Beek who died at age 48 in February. Although the US Preventive Services Task Force lowered recommended screening age to 45 in 2021, experts emphasize that colonoscopy and other screening methods remain essential for early detection and prevention
.
Memorial Sloan Kettering Advances Cancer Immunotherapy Research
New MSK research reveals that the protein TOX plays distinct roles in different immune cells, offering insights to improve precision immunotherapies for cancer treatment. Additionally, a phase 3 trial demonstrates that combining belzutifan and lenvatinib is more effective than standard cabozantinib treatment for advanced kidney cancer, with 47.2% of patients achieving substantial tumor shrinkage compared to 39.1% in the control group
.
Amplifon Launches Global Hearing Health Initiatives for World Hearing Day
The global hearing care leader Amplifon is conducting worldwide awareness campaigns on World Hearing Day (March 3, 2026) across Italy, France, the US, Canada, Australia, and Latin America, featuring free hearing tests and employee training activities. The company is promoting a social media campaign called 'Everyday Hearing Tests' to emphasize the importance of regular hearing checkups and the emotional value of sound
.
Canada Invites Public Input on First-Ever Men and Boys' Health Strategy
The Government of Canada is launching a consultation to develop the country's first Men and Boys' Health Strategy, citing concerning health statistics including men being 3 times more likely than women to die by suicide and 72% of apparent opioid toxicity deaths occurring among males between July 2024 and June 2025. The initiative also addresses social isolation and harmful online spaces as growing health risks for boys and men
.
Breakthrough Funding for Anti-Microbial Resistance Research Announced
CARB-X has launched a 2026 funding round addressing the global antimicrobial resistance burden, with four distinct product themes including direct-acting therapeutics for Gram-negative bacteria and non-vaccine approaches to prevent neonatal sepsis. The funding initiative also supports diagnostic development for neonatal sepsis, recognizing AMR as a critical global health challenge
.
PrecisionLife Advances Personalized GLP-1 Drug Response Prediction
PrecisionLife and Ovation.io announced results from the first phase of their collaboration to develop biomarkers that can quantitively predict the efficacy, safety, and tolerability of glucagon-like peptide-1 receptor agonist (GLP-1) therapies. This precision medicine approach represents significant progress in personalizing treatment for metabolic disorders
.
Health Canada Approves Ozempic for Cardiovascular Risk Reduction in Type 2 Diabetes
Health Canada has approved Ozempic (semaglutide injection) as an adjunct to diet, exercise, and standard care to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes. This approval expands the therapeutic applications of semaglutide beyond glucose control to cardiovascular protection
.
ACP Recommends RSV Vaccination for All Adults 75 and Older
The American College of Physicians (ACP) advises that all adults age 75 and older should receive a protein subunit RSV (respiratory syncytial virus) vaccine. This recommendation addresses respiratory infection risks in elderly populations with guidance released on March 2, 2026
.
IAEA Demonstrates Image-Guided Cervical Cancer Treatment for Resource-Limited Settings
An International Atomic Energy Agency-led study reveals that image-guided brachytherapy can be successfully implemented in hospitals with limited resources, offering improved treatment outcomes for cervical cancer patients. This finding has significant implications for expanding access to advanced cancer treatment in low-resource settings globally
.